Prediction and Mapping of Intraprostatic Tumor Extent with Artificial Intelligence. European urology open science Priester, A., Fan, R. E., Shubert, J., Rusu, M., Vesal, S., Shao, W., Khandwala, Y. S., Marks, L. S., Natarajan, S., Sonn, G. A. 2023; 54: 20-27

Abstract

Background: Magnetic resonance imaging (MRI) underestimation of prostate cancer extent complicates the definition of focal treatment margins.Objective: To validate focal treatment margins produced by an artificial intelligence (AI) model.Design setting and participants: Testing was conducted retrospectively in an independent dataset of 50 consecutive patients who had radical prostatectomy for intermediate-risk cancer. An AI deep learning model incorporated multimodal imaging and biopsy data to produce three-dimensional cancer estimation maps and margins. AI margins were compared with conventional MRI regions of interest (ROIs), 10-mm margins around ROIs, and hemigland margins. The AI model also furnished predictions of negative surgical margin probability, which were assessed for accuracy.Outcome measurements and statistical analysis: Comparing AI with conventional margins, sensitivity was evaluated using Wilcoxon signed-rank tests and negative margin rates using chi-square tests. Predicted versus observed negative margin probability was assessed using linear regression. Clinically significant prostate cancer (International Society of Urological Pathology grade =2) delineated on whole-mount histopathology served as ground truth.Results and limitations: The mean sensitivity for cancer-bearing voxels was higher for AI margins (97%) than for conventional ROIs (37%, p<0.001), 10-mm ROI margins (93%, p=0.24), and hemigland margins (94%, p<0.001). For index lesions, AI margins were more often negative (90%) than conventional ROIs (0%, p<0.001), 10-mm ROI margins (82%, p=0.24), and hemigland margins (66%, p=0.004). Predicted and observed negative margin probabilities were strongly correlated (R2=0.98, median error=4%). Limitations include a validation dataset derived from a single institution's prostatectomy population.Conclusions: The AI model was accurate and effective in an independent test set. This approach could improve and standardize treatment margin definition, potentially reducing cancer recurrence rates. Furthermore, an accurate assessment of negative margin probability could facilitate informed decision-making for patients and physicians.Patient summary: Artificial intelligence was used to predict the extent of tumors in surgically removed prostate specimens. It predicted tumor margins more accurately than conventional methods.

View details for DOI 10.1016/j.euros.2023.05.018

View details for PubMedID 37545845